Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients

NCT02757443 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

NETWORK

Sponsor class

Conditions

Cardiac Surgical Procedures
Heart Valve Prosthesis Implantation

Interventions

DRUG: Phosphocreatine sodium tetrahydrate after anaesthesia induction
DRUG: 5% Glucose after anaesthesia induction
DRUG: Phosphocreatine sodium tetrahydrate added to cardioplegia
DRUG: 5% Glucose
DRUG: Phosphocreatine sodium tetrahydrate after heart recovery
DRUG: 5% Glucose after heart recovery
DRUG: Phosphocreatine sodium tetrahydrate after ICU admission
DRUG: 5% Glucose after ICU admission

Sponsor

Meshalkin Research Institute of Pathology of Circulation